Abstract:Peroxisome proliferator-activated receptor gamma (PPAR-γ) serves as a nuclear receptor with a pivotal function in governing diverse facets of metabolic processes. In diabetes, the prime physiological role of PPAR-γ is to enhance insulin sensitivity and regulate glucose metabolism. Although PPAR-γ agonists such as Thiazolidinediones are effective in addressing diabetes complications, it is vital to be mindful that they are associated with substantial side effects that could potentially give rise to health challenges. The recent surge in the discovery of selective modulators of PPAR-γ inspired us to formulate an integrated computational strategy by leveraging the promising capabilities of both machine learning and in silico drug design approaches. In pursuit of our objectives, the initial stage of our work involved constructing an advanced machine learning classification model, which was trained utilizing chemical information and physicochemical descriptors obtained from known PPAR-γ modulators. The subsequent application of machine learning-based virtual screening, using a library of 31,750 compounds, allowed us to identify 68 compounds having suitable characteristics for further investigation. In total of four compounds were identified and the most favorable configurations were complemented with docking scores ranging from −8.0 to −9.1 kcal/mol. Additionally, the compounds engaged in hydrogen bond interactions with essential conserved residues including His323, Leu330, Phe363, His449 and Tyr473 that describe the ligand binding site. The stability indices investigated herein for instance root-mean-square fluctuations in the backbone atoms indicated higher mobility in the region of orthosteric site in the presence of agonist with the deviation peaks in the range of 0.07–0.69 nm, signifying moderate conformational changes. The deviations at global level revealed the average values of 0.25–0.32 nm. In conclusion, our identified hits particularly, CHEMBL-3185642 and CHEMBL-3554847 presented with outstanding results and highlighted the stable conformation within the orthosteric site of PPAR-γ to positively modulate the activity.

Binding analyses between Human PPARgamma-LBD and ligands.

Binding analyses between Human PPARgamma-LBD and ligands. Surface plasmon resonance biosensor assay correlating with circular dichroic spectroscopy determination and molecular docking

Bindings of PPAR<sub></sub> ligand-binding domain with 5-cholesten-3, 25-diol, 3-sulfate: accurate prediction by molecular simulation

Ligand‐binding Regulation of LXR/RXR and LXR/PPAR Heterodimerizations: SPR Technology‐based Kinetic Analysis Correlated with Molecular Dynamics Simulation

Bivalent Affinity Binding-Inspired PPARγ Immobilization with Selective Conformation and Improved Ligand-Binding Activity

Exploring the Binding Site Structure of the PPARγ Ligand-Binding Domain by Computational Solvent Mapping

Site-selective Covalent Immobilization of PPARγ Using a Label-Free Strategy for Chromatographic Study

Spectroscopic and Molecular Modeling Approaches to Investigate the Interaction of Bisphenol A, Bisphenol F and Their Diglycidyl Ethers with PPARα.

Virtual identification of novel peroxisome proliferator-activated receptor (PPAR) α/δ dual antagonist by 3D-QSAR, molecule docking and molecule dynamics simulation.

The molecular mechanism of hPPAR alpha activation

Exploring Dual Agonists for PPARα/γ Receptors Using Pharmacophore Modeling, Docking Analysis and Molecule Dynamics Simulation.

Unanticipated mechanisms of covalent inhibitor and synthetic ligand cobinding to PPARgamma

Computational Investigation of Ligand Binding to the Peripheral Site in CYP3A4: Conformational Dynamics and Inhibitor Discovery.

Structural mechanism underlying ligand binding and activation of PPARγ

Elucidating the Binding Mechanism of LPA Species and Analogs in an LPA4 Receptor Homology Model

Identification of Novel PPARα/γ Dual Agonists by Virtual Screening, ADMET Prediction and Molecular Dynamics Simulations.

Identification of Novel PPARα/γ Dual Agonists by Pharmacophore Screening, Docking Analysis, ADMET Prediction and Molecular Dynamics Simulations.

Uncovering PPAR-γ agonists: An integrated computational approach driven by machine learning

Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer

Molecular Docking and Molecular Dynamics Simulation Studies of GPR40 Receptor–agonist Interactions

Interpretation of the Binding Affinities of PTP1B Inhibitors with the MM-GB/SA Method and the X-score Scoring Function.